NYC Health + Hospitals has published a guide to help hospitals and health systems plan and train for emerging infectious disease threats, and customize their plans specific to their unique clinical, operational and financial needs. “All hospitals must be prepared to identify and isolate a patient presenting with a suspected special pathogen infection (i.e., one that is particularly virulent and requires care processes and personal protective equipment beyond daily infection control practices) and inform internal and external stakeholders,” the guide states. “This document provides high-level planning guidance for a frontline hospital multidisciplinary team … to support planning and training for the provision of initial care to such patients while determining whether and when the patient will be transferred to another facility for further assessment and treatment.” In a recent Readiness Advisory, AHA urged hospitals to become familiar with the U.S. Regional Treatment Network for Ebola and Other Special Pathogens and understand their facility’s designated role as part of the network.

Related News Articles

Headline
Antimicrobial-resistant infections remained above pre-pandemic levels in 2022, the Centers for Disease Control and Prevention reported July 16. CDC data show…
Headline
The Centers for Disease Control and Prevention July 14 announced four confirmed human cases of H5N1 bird flu among farm workers who were working at a Colorado…
Headline
The Administration for Strategic Preparedness and Response June 25 announced a flu pandemic preparedness and response strategy in response to the threat of…
Headline
The Centers for Disease Control and Prevention June 25 issued a Health Alert Network Health Advisory about an increased risk of dengue virus infections in the…
Headline
The AHA June 13 released an infographic highlighting the many ways hospitals and health systems advance health and support their communities. Among other…
Headline
The Food and Drug Administration last week granted enforcement discretion for the use of conjunctival swabs by laboratories as part of human testing for H5N1…